Canada Drug Delivery Devices Market Size & Outlook

The drug delivery devices market in Canada is expected to reach a projected revenue of US$ 35,862.9 million by 2033. A compound annual growth rate of 8.3% is expected of Canada drug delivery devices market from 2026 to 2033.
Revenue, 2025 (US$M)
$18,985.6
Forecast, 2033 (US$M)
$35,862.9
CAGR, 2026 - 2033
8.3%
Report Coverage
Canada

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Canada drug delivery devices market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Canada drug delivery devices market highlights

  • The Canada drug delivery devices market generated a revenue of USD 18,985.6 million in 2025 and is expected to reach USD 35,862.9 million by 2033.
  • The Canada market is expected to grow at a CAGR of 8.3% from 2026 to 2033.
  • In terms of segment, inhalers was the largest revenue generating product in 2025.
  • Injection Devices is the most lucrative product segment registering the fastest growth during the forecast period.


Drug delivery devices market data book summary

Market revenue in 2025USD 18,985.6 million
Market revenue in 2033USD 35,862.9 million
Growth rate8.3% (CAGR from 2026 to 2033)
Largest segmentInhalers
Fastest growing segmentInjection Devices
Historical data2021 - 2024
Base year2025
Forecast period2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationInhalers, Nebulizers, Injection Devices, Transdermal Patches, Infusion Pumps, Implants, Topical Delivery System, Oral Delivery System, Occular Delivery System
Key market players worldwidePfizer Inc, Johnson & Johnson, Roche Holding AG, Novartis AG ADR, Bayer AG, UniQure NV, BD, SiBiono GeneTech


Other key industry trends

  • In terms of revenue, Canada accounted for 4.1% of the global drug delivery devices market in 2025.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In North America, U.S. drug delivery devices market is projected to lead the regional market in terms of revenue in 2033.
  • Mexico is the fastest growing regional market in North America and is projected to reach USD 23,716.3 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Drug Delivery Devices Market Companies

Name Profile # Employees HQ Website
Terumo Corporation View profile 5001-10000 Tokyo, Tokyo, Japan, Asia http://www.terumo.co.jp/
Gerresheimer AG ADR View profile 11660 Klaus-Bungert-Strasse 4, Duesseldorf, NW, Germany, 40468 https://www.gerresheimer.com
W.L. Gore & Associates View profile 5001-10000 Newark, New Jersey, United States, North America http://www.gore.com
Teleflex Inc View profile 14500 550 East Swedesford Road, Suite 400, Wayne, PA, United States, 19087 https://www.teleflex.com
Boston Scientific Corp View profile 48000 300 Boston Scientific Way, Marlborough, MA, United States, 01752-1234 https://www.bostonscientific.com
Stryker Corp View profile 52000 1941 Stryker Way, Portage, MI, United States, 49002 https://www.stryker.com
Medtronic PLC View profile 95000 Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 https://www.medtronic.com
Becton Dickinson & Co View profile 73000 1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880 https://www.bd.com
Abbott Laboratories View profile 114000 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 https://www.abbottinvestor.com
Novartis AG ADR View profile 76057 Lichtstrasse 35, Basel, Switzerland, 4056 https://www.novartis.com

Canada drug delivery devices market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug delivery devices market will help companies and investors design strategic landscapes.


Inhalers was the largest segment with a revenue share of 26.09% in 2025. Horizon Databook has segmented the Canada drug delivery devices market based on inhalers, nebulizers, injection devices, transdermal patches, infusion pumps, implants, topical delivery system, oral delivery system, occular delivery system covering the revenue growth of each sub-segment from 2021 to 2033.


The presence of developed healthcare infrastructure, increasing number of surgical procedures, rising number of healthcare centers, and launch of new products are some of the key factors driving market growth. 

For instance, in April 2021, Teva Canada launched a new autoinjector for AJOVY, a subcutaneous injection for preventive migraine treatment in adults. AJOVY offers two dosing options (quarterly or monthly) available in both a prefilled syringe and an autoinjector, providing patients greater flexibility. 

Reasons to subscribe to Canada drug delivery devices market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Canada drug delivery devices market databook

  • Our clientele includes a mix of drug delivery devices market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Canada drug delivery devices market , including forecasts for subscribers. This country databook contains high-level insights into Canada drug delivery devices market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Canada drug delivery devices market size, by product, 2021-2033 (US$M)

Canada Drug Delivery Devices Market Outlook Share, 2025 & 2033 (US$M)

Canada drug delivery devices market size, by product, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online